Co-infection associated with SARS-CoV-2 and their management

Vivek P Chavda*, Aayushi B Patel, Anjali Pandya, Lalitkumar K Vora, Vandana Patravale, Zara M Tambuwala, Alaa AA Aljabali, Ángel Serrano-Aroca, Vijay Mishra, Murtaza M Tambuwala*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

4 Downloads (Pure)

Abstract

SARS-CoV-2 was discovered in Wuhan, China and quickly spread throughout the world. This deadly virus moved from person to person, resulting in severe pneumonia, fever, chills and hypoxia. Patients are still experiencing problems after recovering from COVID-19. This review covers COVID-19 and associated issues following recovery from COVID-19, as well as multiorgan damage risk factors and treatment techniques. Several unusual illnesses, including mucormycosis, white fungus infection, happy hypoxia and other systemic abnormalities, have been reported in recovered individuals. In children, multisystem inflammatory syndrome with COVID-19 (MIS-C) is identified. The reasons for this might include uncontrollable steroid usage, reduced immunity, uncontrollable diabetes mellitus and inadequate care following COVID-19 recovery.
Original languageEnglish
Article numberFSO819
JournalFuture Science OA
Volume8
Issue number9
Early online date03 Feb 2023
DOIs
Publication statusEarly online date - 03 Feb 2023

Keywords

  • Review
  • antiphospholipid syndrome
  • chronic pulmonary disease
  • co-infections
  • COVID-19 complications
  • COVID-19 life cycle
  • happy hypoxia
  • immuno-oncological challenges
  • MIS-C
  • mucormycosis
  • risk factors
  • SARS-CoV-2
  • systemic disorders

Fingerprint

Dive into the research topics of 'Co-infection associated with SARS-CoV-2 and their management'. Together they form a unique fingerprint.

Cite this